| Co2(CO)8 as a Solid CO (g) Source for the Amino Carbonylation of (Hetero)aryl Halides with Highly Deactivated (Hetero)arylamines S Cheruku, AM Sajith, Y Narayana, P Shetty, SC Nagarakere, KS Sagar, ... The Journal of Organic Chemistry 86 (8), 5530-5537, 2021 | 25 | 2021 |
| IDO inhibitors JA Balog, EC Cherney, W Guo, A Huang, JA Markwalder, SP Seitz, ... US Patent 9,790,169, 2017 | 25 | 2017 |
| BMS-986163, a negative allosteric modulator of GluN2B with potential utility in major depressive disorder LR Marcin, J Warrier, S Thangathirupathy, J Shi, GN Karageorge, ... ACS Medicinal Chemistry Letters 9 (5), 472-477, 2018 | 16 | 2018 |
| Discovery of BMS-986339, a pharmacologically differentiated farnesoid X receptor agonist for the treatment of nonalcoholic steatohepatitis SJ Nara, S Jogi, S Cheruku, S Kandhasamy, F Jaipuri, PK Kathi, S Reddy, ... Journal of Medicinal Chemistry 65 (13), 8948-8960, 2022 | 13 | 2022 |
| Synthesis and antimicrobial evaluation of novel 4-amino-6-(1, 3, 4-oxadiazolo/1, 3, 4-thiadiazolo)-pyrimidine derivatives P Shetty, BM Praveen, M Raghavendra, K Manjunath, S Cheruku Molecular diversity 20, 391-398, 2016 | 10 | 2016 |
| An efficient synthesis of medicinally important indole based triarylmethanes by using propylphosphonic anhydride (T3P®) S Cheruku, C Nagaraju, P Shetty, S Hassan A, S Nagarakere C, ... Synthetic Communications 50 (10), 1486-1494, 2020 | 6 | 2020 |
| Inhibitors of indoleamine-2, 3-dioxygenase for the treatment of cancer JA Balog, EC Cherney, JA Markwalder, SP Seitz, W Shan, DK Williams, ... US Patent 10,399,932, 2019 | 3 | 2019 |
| Inhibitors of indoleamine 2, 3-dioxygenase for the treatment of cancer JA Balog, EC CHERNEY, W Guo, A Huang, JA Markwalder, SP Seitz, ... | 3 | 2016 |
| An expedient, efficient and solvent-free synthesis of T3P®-mediated amidation of benzhydrols with poorly reactive N-nucleophiles under MW irradiation S Cheruku, SC Nagarakere, MP Sunilkumar, Y Narayana, ... New Journal of Chemistry 46 (9), 4421-4426, 2022 | 2 | 2022 |
| Bridged bicyclic compounds as farnesoid X receptor modulators DS Yoon, RK Anumula, S Cheruku, Y Huang, EA Jurica, W Meng, ... US Patent 10,730,863, 2020 | 2 | 2020 |
| Selective NR2B antagonists I Islam, S Thangathirupathy, JS Warrier, S Cheruku, P Shetty, JE Macor US Patent 10,501,451, 2019 | 2 | 2019 |
| IDO inhibitors JA Balog, EC Cherney, W Guo, A Huang, JA Markwalder, SP Seitz, ... US Patent 10,167,254, 2019 | 2 | 2019 |
| Inhibitors of indoleamine 2, 3-dioxygenase and methods of their use JA Balog, JA Markwalder, W Shan, DK Williams, SJ Nara, S Roy, ... US Patent 12,059,420, 2024 | 1 | 2024 |
| Inhibitors of indoleamine 2, 3-dioxygenase and methods of their use JA Balog, SP Seitz, SJ Nara, S Roy, S Thangathirupathy, S Thangavel, ... US Patent 11,253,525, 2022 | 1 | 2022 |
| Substituted bicyclic compounds as farnesoid x receptor modulators DA Wacker, SJ NARA, S CHERUKU, K SARKUNAM, FA JAIPURI, ... | 1 | 2021 |
| Inhibitors of indoleamine 2, 3-dioxygenase and methods of their use JA Balog, SP Seitz, JA Markwalder, DK Williams, W Shan, SJ Nara, S Roy, ... US Patent App. 17/261,968, 2021 | 1 | 2021 |
| Selective NR2B antagonists I Islam, S Thangathirupathy, JS Warrier, S Cheruku, P Shetty, ... US Patent 10,344,020, 2019 | 1 | 2019 |
| Substituted amide compounds useful as farnesoid X receptor modulators DA Wacker, SJ Nara, S Cheruku, K Sarkunam, FA Jaipuri, S Thangavel, ... US Patent 12,030,835, 2024 | | 2024 |
| Substituted bicyclic compounds as farnesoid X receptor modulators DA Wacker, SJ Nara, S Cheruku, K Sarkunam, FA Jaipuri, S Thangavel, ... US Patent 11,713,312, 2023 | | 2023 |
| Substituted bicyclic compounds as farnesoid x receptor modulators DA Wacker, SJ Nara, S Cheruku, K Sarkunam, FA Jaipuri, R Narayan, ... US Patent App. 17/431,006, 2022 | | 2022 |
